• No results found

18 results with keyword: 'photodynamic therapy treatment choroidal neovascularization complicating central chorioretinopathy'

Photodynamic Therapy in the Treatment of Choroidal Neovascularization Complicating Central Serous Chorioretinopathy

Indocyanine green angiography (ICGA) revealed subfoveal CNV with hyperfluorescence dye leakage in the right eye (Figure 2A), and multiple areas of choroidal vascular

Protected

N/A

5
0
0
2021
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis

Subfoveal choroidal thickness after photodynamic therapy in patients with acute idio- pathic central serous chorioretinopathy. Chronic central serous chorioretinopathy is

Protected

N/A

37
0
0
2021
Pachychoroid Diseases of the Macula

Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy. Subfoveal

Protected

N/A

5
0
0
2021
Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization

Laser photocoagulation, photodynamic therapy, and intravitreal bevaci- zumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic

Protected

N/A

6
0
0
2020
Long-term follow-up of choroidal neovascularization secondary to angioid streaks: case series and literature review

Combination treatment with intravitreal injection of ranibizumab and reduced fluence photodynamic therapy for choroidal neovascularization secondary to angioid streaks:

Protected

N/A

6
0
0
2020
Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions

Data from the Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) study showed that verteporfin therapy of subfoveal choroidal neovascularization (CNV)

Protected

N/A

6
0
0
2020
Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: a

Protected

N/A

8
0
0
2020
BAL 002 2(i) Disturbance Control Standard Contingency Reserve for Recovery from a Balancing Contingency Event

The Responsible Entity  achieved less than  70% of required  recovery from a  Reportable Balancing  Contingency Event  during the .

Protected

N/A

10
0
0
2021
Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy

BCVA: best corrected visual acuity; CCSCR: chronic central serous chorioretinopathy; CNV: choroidal neovascularization; CRT: central retinal thickness; CRTA: central retinal

Protected

N/A

9
0
0
2020
Article I. Definitions

The User is reminded that, by virtue of current legislation, ONLINE is not subject to a general obligation to monitor information provided by Users; nevertheless ONLINE may be

Protected

N/A

10
0
0
2021
Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy

ASP: Automated static perimetry; BCVA: Best-corrected visual acuity; CFT: Central foveal thickness; CNV: Choroidal neovascularization; CSCR: Central serous chorioretinopathy;

Protected

N/A

6
0
0
2020
Understanding Atrial Fibrillation/ Atrial Flutter (AF/AFL)

The risk of dofetilide induced ventricular arrhythmia was assessed in three ways in clinical studies: 1) by description of the QT interval and its relation to the dose and

Protected

N/A

21
0
0
2021
Central serous chorioretinopathy

102 Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK: Choroidal vascular remodel- ling in central serous chorioretinopathy af- ter indocyanine green guided photodynamic therapy

Protected

N/A

12
0
0
2021
A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration

Intravitreal bevacizumab alone versus combined verteporfin photodynamic therapy and intravitreal bevacizumab for choroidal neovascularization in age- related macular

Protected

N/A

7
0
0
2020
Diagnostic accuracy of optical coherence tomography angiography for choroidal neovascularization: a systematic review and meta-analysis

AMD: Age-related macular degeneration; CNV: Choroidal neovascularization; CSCR: Central serous chorioretinopathy; DOR: Diagnostic odds ratio; FA: Fluorescein angiography;

Protected

N/A

9
0
0
2020
Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report

AMD: age related macular degeneration; BCVA: best-corrected visual acuity; CNV: choroidal neovascularization; CSC: central serous chorioretinopathy; FA: fluorescent angiograph;

Protected

N/A

6
0
0
2020
Seung-Ju Yoon University of Tennessee - Knoxville. Follow this and additional works at:

5.8 Monitored and predicted PM 2.5 concentrations and meteorological parameters under unstable atmospheric conditions immediately after a heavy rain with the

Protected

N/A

163
0
0
2021
Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy

AMD: Age-related macular degeneration; CNV: Choroidal neovascularization; CSC: Central serous chorioretinopathy; FGF: Fibroblast growth factor; OCT: Optical coherence tomography;

Protected

N/A

5
0
0
2020

Upload more documents and download any material studies right away!